Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-11

Clinical Trial Update: Diazoxide Suppression Test P&F Study [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from Columbia University describes a Diazoxide suppression test for insulin resistance, hyperinsulinemia, and obesity, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIAZOXIDE (DIAZOXIDE)

Snippet

Sponsor: Columbia University | Conditions: Insulin Resistance, Hyperinsulinemia | Phase 1 | Status: RECRUITING